These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 22503001

  • 1. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
    Mosconi L, Rinne JO, Tsui WH, Murray J, Li Y, Glodzik L, McHugh P, Williams S, Cummings M, Pirraglia E, Goldsmith SJ, Vallabhajosula S, Scheinin N, Viljanen T, Någren K, de Leon MJ.
    Neurobiol Aging; 2013 Jan; 34(1):22-34. PubMed ID: 22503001
    [Abstract] [Full Text] [Related]

  • 2. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
    Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ.
    Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):5949-54. PubMed ID: 20231448
    [Abstract] [Full Text] [Related]

  • 3. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Någren K, Kim BC, Tsui W, de Leon MJ.
    Eur J Nucl Med Mol Imaging; 2008 Dec 30; 35(12):2169-81. PubMed ID: 18566819
    [Abstract] [Full Text] [Related]

  • 4. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2014 Dec 30; 4():508-16. PubMed ID: 24818077
    [Abstract] [Full Text] [Related]

  • 5. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S, Yousefi BH, Wester HJ, Klupp E, Rominger A, Förstl H, Kurz A, Grimmer T, Drzezga A.
    Eur J Nucl Med Mol Imaging; 2012 Dec 30; 39(12):1927-36. PubMed ID: 22926714
    [Abstract] [Full Text] [Related]

  • 6. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ.
    J Neurosci; 2013 Mar 27; 33(13):5553-63. PubMed ID: 23536070
    [Abstract] [Full Text] [Related]

  • 7. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.
    Brain; 2012 Jul 27; 135(Pt 7):2115-25. PubMed ID: 22556189
    [Abstract] [Full Text] [Related]

  • 8. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 9. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov 15; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 10. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD.
    J Neurol Neurosurg Psychiatry; 2014 Mar 15; 85(3):266-73. PubMed ID: 23965289
    [Abstract] [Full Text] [Related]

  • 11. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H, Madison C, Baker S, Rabinovici G, Jagust W.
    Brain; 2016 Aug 15; 139(Pt 8):2275-89. PubMed ID: 27190008
    [Abstract] [Full Text] [Related]

  • 12. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
    Sang S, Pan X, Chen Z, Zeng F, Pan S, Liu H, Jin L, Fei G, Wang C, Ren S, Jiao F, Bao W, Zhou W, Guan Y, Zhang Y, Shi H, Wang Y, Yu X, Wang Y, Zhong C.
    Alzheimers Res Ther; 2018 Mar 01; 10(1):26. PubMed ID: 29490669
    [Abstract] [Full Text] [Related]

  • 13. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
    Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ.
    Neurology; 2007 Feb 13; 68(7):501-8. PubMed ID: 17065593
    [Abstract] [Full Text] [Related]

  • 14. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.
    Brain; 2008 Mar 13; 131(Pt 3):665-80. PubMed ID: 18263627
    [Abstract] [Full Text] [Related]

  • 15. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ.
    JAMA Neurol; 2013 Dec 13; 70(12):1512-9. PubMed ID: 24166579
    [Abstract] [Full Text] [Related]

  • 16. FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease.
    Murray J, Tsui WH, Li Y, McHugh P, Williams S, Cummings M, Pirraglia E, Solnes L, Osorio R, Glodzik L, Vallabhajosula S, Drzezga A, Minoshima S, de Leon MJ, Mosconi L.
    Adv J Mol Imaging; 2014 Apr 13; 4(2):15-26. PubMed ID: 25530915
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, Johnson KA.
    JAMA Neurol; 2018 May 01; 75(5):548-556. PubMed ID: 29435558
    [Abstract] [Full Text] [Related]

  • 20. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.
    Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ.
    Brain; 2010 Feb 01; 133(Pt 2):512-28. PubMed ID: 20080878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.